| Jessica Ann Ward, DO | |
|
4830 Londonderry Rd, Harrisburg, PA 17109-5207 | |
| (717) 657-2595 | |
| (717) 657-3091 |
| Full Name | Jessica Ann Ward |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 4830 Londonderry Rd, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730370800 | NPI | - | NPPES |
| 1021703250001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | OS013950 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc. | Harrisburg, PA | Home health agency |
| Heartland Hospice Services, Inc | York, PA | Hospice |
| Kindred Hospice | Camp hill, PA | Hospice |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Practice Center Pc | 0244124212 | 265 |
News Archive
A major goal of hospitals is to prevent unplanned readmissions of patients after they are discharged. A new study reveals that the preventability of readmissions changes over time: readmissions within the first week after discharge are often preventable by the hospital, whereas readmissions later are often related to patients' difficultly accessing outpatient clinics.
Following US and European approvals of Elekta's Versa HD™ linear accelerator, the China Food and Drug Administration (CFDA) has cleared the radiation therapy system for sale and marketing in the country.
A federally funded study by Johns Hopkins Medicine researchers shows that wearable accelerometers - mechanical sensors worn like a watch, belt or bracelet to track movement - are a more reliable measure of physical activity and better than patient surveys and other methods used by physicians at assessing five-year risk of death in older adults.
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 2 days ago
| Entity Name | Family Practice Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154376937 PECOS PAC ID: 0244124212 Enrollment ID: O20040211000012 |
News Archive
A major goal of hospitals is to prevent unplanned readmissions of patients after they are discharged. A new study reveals that the preventability of readmissions changes over time: readmissions within the first week after discharge are often preventable by the hospital, whereas readmissions later are often related to patients' difficultly accessing outpatient clinics.
Following US and European approvals of Elekta's Versa HD™ linear accelerator, the China Food and Drug Administration (CFDA) has cleared the radiation therapy system for sale and marketing in the country.
A federally funded study by Johns Hopkins Medicine researchers shows that wearable accelerometers - mechanical sensors worn like a watch, belt or bracelet to track movement - are a more reliable measure of physical activity and better than patient surveys and other methods used by physicians at assessing five-year risk of death in older adults.
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Ann Ward, DO 7 Dock Hill Rd, Middleburg, PA 17842-8910 Ph: (570) 837-2123 | Jessica Ann Ward, DO 4830 Londonderry Rd, Harrisburg, PA 17109-5207 Ph: (717) 657-2595 |
News Archive
A major goal of hospitals is to prevent unplanned readmissions of patients after they are discharged. A new study reveals that the preventability of readmissions changes over time: readmissions within the first week after discharge are often preventable by the hospital, whereas readmissions later are often related to patients' difficultly accessing outpatient clinics.
Following US and European approvals of Elekta's Versa HD™ linear accelerator, the China Food and Drug Administration (CFDA) has cleared the radiation therapy system for sale and marketing in the country.
A federally funded study by Johns Hopkins Medicine researchers shows that wearable accelerometers - mechanical sensors worn like a watch, belt or bracelet to track movement - are a more reliable measure of physical activity and better than patient surveys and other methods used by physicians at assessing five-year risk of death in older adults.
Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
› Verified 2 days ago
Lindsey Marie Govern, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Sir Thomas Ct Ste 101, Harrisburg, PA 17109 Phone: 717-614-4420 Fax: 717-614-4421 | |
Quan Tran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8772 | |
Richard Haley Jeffries, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4830 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-657-2595 Fax: 717-657-3091 | |
Joanne G Gordon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-782-3380 Fax: 717-782-5716 | |
Dr. David Edward Dudick, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Internal Medicine Residency Program, Brady Hall 3, Harrisburg, PA 17101 Phone: 717-782-3131 | |
Emily Ramasra, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8506 | |
Mr. Siddharth Goel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 S Front St Upmc Pinnacle, Internal Medicine Residen, Suite 3c, Harrisburg, PA 17104 Phone: 717-231-8506 Fax: 717-231-8535 |